NYSE : MTD
Mettler-Toledo International Inc. — Key statistics
Healthcare · Diagnostics & Research · Switzerland
Last price 1674.81 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 33.56B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 33.56B |
| Enterprise Value | 35.64B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 20.04M |
| Shares Outstanding | 20.04M |
| Shares Change (YoY) | -2.98% |
| Shares Change (QoQ) | -0.85% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 103.99% |
| Float | 19.93M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 37.68 |
| Forward PE | 33.94 |
| PS Ratio | 8.12 |
| Forward PS | 7.75 |
| PB Ratio | 2,616.97 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 38.84 |
| P/OCF Ratio | 34.41 |
| PEG Ratio | 3.24 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 39.36 |
| EV / Sales | 8.62 |
| EV / EBITDA | 27.94 |
| EV / EBIT | 29.86 |
| EV / FCF | 41.26 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.12 |
| Quick Ratio | 0.66 |
| Debt / Equity | 166.68 |
| Debt / EBITDA | 1.61 |
| Debt / FCF | 2.47 |
| Interest Coverage | 17.21 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 21.10% |
| Return on Invested Capital (ROIC) | 42.28% |
| Return on Capital Employed (ROCE) | 48.31% |
| Weighted Average Cost of Capital (WACC) | 10.29% |
| Revenue Per Employee | $228,391 |
| Profits Per Employee | $50,034 |
| Employee Count | 18,100 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 4.11 |
Taxes
| Measure | Value |
|---|
| Income Tax | 191.76M |
| Effective Tax Rate | 17.47% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +20.13% |
| 50-Day Moving Average | 1,494.05 |
| 200-Day Moving Average | 1,337.49 |
| Relative Strength Index (RSI) | 65.43 |
| Average Volume (20 Days) | 198,858 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 657,655 |
| Short Previous Month | 697,792 |
| Short % of Shares Out | 3.28% |
| Short % of Float | 3.30% |
| Short Ratio (days to cover) | 2.85 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.13B |
| Gross Profit | 2.49B |
| Operating Income | 1.19B |
| Pretax Income | 1.10B |
| Net Income | 905.61M |
| EBITDA | 1.28B |
| EBIT | 1.19B |
| Earnings Per Share (EPS) | $44.45 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 51.38M |
| Total Debt | 2.14B |
| Net Cash | -2.09B |
| Net Cash Per Share | -$104.11 |
| Equity (Book Value) | 12.82M |
| Book Value Per Share | 0.64 |
| Working Capital | 146.89M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 975.17M |
| Capital Expenditures | -111.20M |
| Depreciation & Amortization | 82.20M |
| Net Borrowing | -48.66M |
| Free Cash Flow | 863.97M |
| FCF Per Share | $43.12 |
Margins
| Measure | Value |
|---|
| Gross Margin | 60.26% |
| Operating Margin | 28.87% |
| Pretax Margin | 26.55% |
| Profit Margin | 21.91% |
| EBITDA Margin | 30.86% |
| EBIT Margin | 28.87% |
| FCF Margin | 20.90% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.98% |
| Shareholder Yield | 2.98% |
| Earnings Yield | 2.65% |
| FCF Yield | 2.57% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1,525.67 |
| Price Target Difference | -8.90% |
| Analyst Consensus | Hold |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 5.01% |
| EPS Growth Forecast (3Y) | 10.41% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 10.29 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |